InsidersTradesSigma
Explore the detailed record of transactions filed by Doerfler Douglas, Chairman & CEO. Director active across 1 companies, notably Maxcyte, INC.. In total, 2 disclosures have been recorded. The latest transaction was filed on 12 November 2021 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Douglas Doerfler is the President and CEO of MaxCyte, Inc. He leads the company with a focus on innovation in biotechnology, developing solutions to enhance medical treatments.